Kevin Zoellner

Kevin Zoellner has extensive experience in the pharmaceutical industry, currently serving as Production Manager at NTP Radioisotopes SOC Ltd since June 2010, where responsibilities include managing the production of Lutetium-177 non-carrier added (n.c.a) for Peptide Receptor Radiation Therapy (PRRT) in treating prostate cancer and neuroendocrine tumors. Previously, Kevin held the position of Department Manager for Radiopharmaceuticals at NTP, overseeing the production of radioactive pharmaceuticals for diagnostic imaging related to various cancers. Prior experience includes serving as a Hospital Pharmacist at Morningside Mediclinic and working in a Retail Pharmacy. Kevin holds a Master of Science (MSc) in Medicinal and Pharmaceutical Chemistry and a Bachelor's Degree in Pharmacy, both obtained from North-West University.